BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1182977)

  • 1. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Lucchesi BR; Kniffen FJ
    Circulation; 1975 Dec; 52(6 Suppl):III241-7. PubMed ID: 1182977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological possibilities for the prevention of complications following myocardial infarction].
    Szekeres L
    J Pharmacol; 1986; 17 Suppl 2():65-81. PubMed ID: 3821131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of antiarrhythmic drugs.
    Lucchesi BR; Lynch JJ
    Fed Proc; 1986 Jul; 45(8):2197-205. PubMed ID: 3720962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction.
    van Dijk L
    Folia Med Neerl; 1971; 14(5):225-36. PubMed ID: 4400908
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
    Billman GE
    J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current anti-arrhythmic treatments and drugs].
    Chiche P; Witchitz S; Naouri L; Philippe B
    Coeur Med Interne; 1973; 12(1):129-44. PubMed ID: 4146955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic significance of arrhythmias in acute myocardial infarction (author's transl)].
    Breithardt G; Seipel L; Loogen F
    Z Kardiol; 1977 Jun; 66(6):267-72. PubMed ID: 331707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT; Giardina EG
    Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac arrhythmias. Rationale of drug therapy.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402
    [No Abstract]   [Full Text] [Related]  

  • 17. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bretylium Tosylate; adverse effects in acute myocardial infarction.
    Luomanmaäki K; Heikkilä J; Härtel G
    Arch Intern Med; 1975 Apr; 135(4):515-8. PubMed ID: 1138664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic therapy for the elderly: a two-edged sword.
    Mehlman DJ; Arnsdorf MF
    Geriatrics; 1979 May; 34(5):29-33, 38-9, 42-9 passim. PubMed ID: 374183
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias.
    Kuck KH; Siebels J; Schneider MA
    Herz; 1995 Jun; 20(3):213-8. PubMed ID: 7635402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.